All pharmaceutical companies today are racing to bring new treatments to market as quickly as possible. They often conduct multiple clinical trials simultaneously for different drugs (combination trials) and also attempt to determine various uses of the same drug (drug repurposing). This can lead to faster approval of the drug and have a broader impact,…

In the journey of pharmaceutical development, strategic comparator sourcing has emerged as a critical factor that can make or break your clinical trial timeline. More than just a supply chain consideration, it often becomes a decisive element for timely market entry. One common challenge many pharmaceutical companies face is sourcing comparator drugs from a specific…

We often hear this common concern from clinical trial managers: "We need a comparator drug from a single batch, and we can’t find it anywhere." Recently, we received a query from our client for a prostate cancer drug approved by the US FDA in 2023. Our client urgently required 300 packs from a single batch,…

Recently, a few clinical trial sponsors approached us because they were facing a challenge in distinguishing between a genuine and counterfeit pack of an Immuno-Oncology Drug.

Imagine a scenario where your clinical trial team orders a reference-listed drug with an approved shelf life of 24 to 36 months. However, when it reaches a clinical trial site, you have an RLD with less than 12 months to use. Case in Point Pertaining to a recent case involving an immuno-oncology blockbuster. Despite its…